Domalagan, Bb Girl -.
HRN: 22-33-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/18/2022
12/25/2022
IV
41mg
Q24
NB Affected By Maternal UTI
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes